EUVIMEDEUVIMED entdecken
Crossref

Thermosensitive Microneedles Capable of On Demand Insulin Release for Precise Diabetes Treatment

Sihao Jiang, Jiayi Bian, Xintong Shi, Yong Hu iD

Macromolecular Bioscience · 2023

DOI: 10.1002/mabi.202300018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, 2023. Verfasst von Sihao Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Foreign Language School, 30 Beijing East Road, Nanjing, 210008, P. R. China. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a novel painless and minimally invasive transdermal drug delivery method, microneedles have solved the challenges of microbial infection and tissue necrosis associated with multiple subcutaneous injections in patients with diabetes. However, traditional soluble microneedles cannot switch drug release on and off according to the patient's needs during long‐term use, which is one of the most critical elements of diabetes treatment. Herein, an insoluble thermosensitive microneedle (ITMN) that can control the release of insulin by adjusting the temperature, enabling the precise treatment of diabetes is designed. Thermosensitive microneedles are produced by in situ photopolymerization of the temperature‐sensitive compound N‐isopropylacrylamide with the hydrophilic monomer N‐vinylpyrrolidone, which is encapsulated with insulin and bound to a mini‐heating membrane. ITMN are demonstrated to have good mechanical strength and temperature sensitivity, can release significantly different insulin doses at different temperatures, and effectively regulate blood glucose in type I diabetic mice. Therefore, the ITMN provides a possibility for intelligent and convenient on‐demand drug delivery for patients with diabetes, and when combined with blood glucose testing devices, it has the potential to form an integrated and precise closed‐loop treatment for diabetes, which is of great importance in diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinDiabetes Mellitus, ExperimentalMiceAnimalsBlood GlucoseAdministration, CutaneousInjections, SubcutaneousDrug Delivery Systems

Stichwörter der Autor:innen

diabetes treatmentdrug deliverytemperature-controlled releasethermosensitive microneedles

Substanzen

InsulinBlood Glucose

Autor:innen und Institutionen

  • Nanjing Foreign Language School, 30 Beijing East Road, Nanjing, 210008, P. R. China.
  • State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P. R. China.
  • Collaborative Innovation Center of Chemistry for Life Sciences, College of Engineering and Applied Sciences, Nanjing University, 163 Xian Lin Da Dao, Nanjing, 210023, P. R. China.

ORCID-Profile: Yong Hu

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Jiang, S., Bian, J., Shi, X., & Hu, Y. (2023). Thermosensitive Microneedles Capable of On Demand Insulin Release for Precise Diabetes Treatment. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202300018

Vancouver

Jiang S, Bian J, Shi X, Hu Y. Thermosensitive Microneedles Capable of On Demand Insulin Release for Precise Diabetes Treatment. Macromolecular Bioscience. 2023. doi:10.1002/mabi.202300018

BibTeX
@article{Jiang2023,
  author = {Jiang, Sihao and Bian, Jiayi and Shi, Xintong and Hu, Yong},
  title = {Thermosensitive Microneedles Capable of On Demand Insulin Release for Precise Diabetes Treatment},
  journal = {Macromolecular Bioscience},
  year = {2023},
  doi = {10.1002/mabi.202300018}
}
Kostenlos starten →